Pangea Bio

Pangea Botanica

This company develops medicines for neurological and mental health disorders using an artificial intelligence platform to discover neuroactive molecules from medicinal plants.

PharmEnable

This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.

Gain Therapeutics

This biotechnology company develops allosteric small molecule therapies for patients with neurodegenerative diseases and rare genetic disorders using an artificial intelligence drug discovery platform.

Biomia

The company develops nature-inspired small molecule therapeutics to treat central nervous system disorders for patients with mental health conditions and chronic pain.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.

Engrail Therapeutics

This company develops small-molecule therapies for patients with neurologic, neuropsychiatric and neurodevelopmental disorders such as anxiety, depression and rare diseases.